Thus, a recent study adapted a well-characterized microfluidic device89 to simulate the lymphatic response to inflammation (local stromal cells release tumor necrosis factor alpha (TNF-α), transforming growth factor-β (TGF-β), and interleukins), which leads to immune cell recruitment to tumors or infection sites through chemotactic signaling in vivo90. The gene discussed is TNF; the disease is infection.